Norwegian Centre for Headache Research

NorHead is a centre for clinical treatment research on headache disorders. Tweets in English and Norwegian.

[Cephalalgia @JCephalalgia]

March's Editor's Choice
@Simona_Sacco_

We are pleased to announce and congratulate the authors on their paper, “Migraine and insufficient sleep: The effect of sleep restriction on nociceptive evoked potentials in migraine” which has been selected as the Editor’s Choice for the March issue of Cephalalgia.

This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders.

.....
This study found that insufficient sleep may increase cortical inhibitory responses to nociceptive stimulation in migraine. This finding supports the idea that migraine is associated with a vulnerability for insufficient sleep.
....
https://t.co/SbkrjyCY59
#migraine #headache #brain #pain #neurology #neuroscience

@PetterOmland
@NorHeadResearch

[Norwegian Centre for Headache Research @NorHeadResearch]

Recent study from @PetterOmland on the impact of insufficient sleep on #migraines. Results show altered pain responses in migraine sufferers compared to controls after reduced sleep. Findings highlight a vulnerability to insufficient sleep between attacks. https://t.co/M67sGcuIOL

[Norwegian Centre for Headache Research @NorHeadResearch]

The NorHead team is ready to welcome you to our stand at the #EHC2024 - International Headache Congress in Rotterdam!

[European Headache Federation @EHF_Official]

Prof. Erling Andreas Tronvik from Trondheim (NO) cordially invites you to the session on "Data science and AI" on and is already looking forward to see you there. In the video, he gives a brief outline of the main points of the session!
👉🏻 https://t.co/5IHKYffmRm
#EHC2024

[Martin Syvertsen Mykland @MyklandMartin]

Grateful for receiving the first Sjaastad Prize in the field of #headache! Honored to be picked by the Norwegian headache society and thankful for bein a part of the 2024 National Headache conference by @NorHeadResearch

[Erling Andreas Tronvik @ErlingTronvik]

Thank you, @GMTerwindt, Nadine Pelzer and Irene de Boer for visiting us at @NorHeadResearch in Trondheim for very interesting discussions and social interactions. 😊

[Erling Andreas Tronvik @ErlingTronvik]

Congratulations Kent Are Jamtøy @Jamtoy79 for well executed PhD defence today !! @NorHeadResearch #headache #facialpain

[Cephalalgia @JCephalalgia]

This paper is a narrative review on the use of artificial intelligence and machine learning in headache conditions. Including an introduction on how to read AI papers in this field.
https://t.co/ylxOHY4dVV
#headache #neurology
@Manjit_Matharu

@ErlingTronvik

@NorHeadResearch

[Cephalalgia @JCephalalgia]

This study found that the prevalence of medically treated migraine in Norway is low, rising from 1.99% in 2010 to 2.99% in 2020. Moreover, triptans are often overused, and preventive coverage is low.
https://t.co/GJ8qHKQk89
#migraine
@NorHEADresearch
@martebjork
@ErlingTronvik

[Faraidoon Haghdoost (Big Head Pain) @faradoost]

Amitriptyline, candesartan, and beta-blockers are the most common first- and second-line migraine therapies, while Botox and CGRP antibodies are more frequently used as later treatment options.
@ErlingTronvik
https://t.co/py4XFM4sL2
#headache #migraine

[Erling Andreas Tronvik @ErlingTronvik]

New paper with real-world data on 261 navigated injections of Botox towards the SPG in cluster headache and migraine @JCephalalgia @NorHeadResearch @ucl @Manjit_Matharu @ihs_official #lucysimmonds #danielbratbak #headache #migraine #clusterheadache https://t.co/6CvA9vp5vG

[Cephalalgia @JCephalalgia]

No increased risk of atrial fibrillation (AF) was found among individuals with migraine or tension-type headache. Individuals with migraine aged ≥55 years had lower risk of AF compared to headache-free people.
https://t.co/QhtTA64nJT
@NorHeadResearch
@alexanol
@ErlingTronvik

[Martin Syvertsen Mykland @MyklandMartin]

People with #migraine had a greater need for sufficient #sleep to maintain cognitice function as reaction time. We have previously reported neurophysiological effects of insufficient sleep: https://t.co/s573DUQz9w #EAN2024 @EANeurology @NorHeadResearch @nevrologi @NTNUhelse

[Erling Andreas Tronvik @ErlingTronvik]

Tore Meisingset @NorHeadResearch had an excellent presentation on SPG intervention in migraine and CH at EAN. Collaboration with UCL. It was also mentioned at the highlight/breaking news session !!
@Manjit_Matharu #ToreMeisingset #EANneurology #EAN2024 @nevrologi

[Erling Andreas Tronvik @ErlingTronvik]

Martin Mykland @NorHeadResearch had an excellent presentation on EAN on how insufficient sleep in migraine patient can cause cognitive impairment. #EANneurology #EAN2024 @MyklandMartin

[Erling Andreas Tronvik @ErlingTronvik]

New paper out on artificial intelligence and headache. @NorHeadResearch @Manjit_Matharu @HelgeLangseth #ankerstubberud #parashkevnatchev @ihs_official #headache #MachineLearning #ai
https://t.co/7xVvrEvkgg

[Erling Andreas Tronvik @ErlingTronvik]

Acute headache and subarachnoid hemorrhage ! @NorHeadResearch #KjerstiAaseth @EspnSaxKristoff @KjerstiVetvik @Ahus_no #headache @EurJournalNeuro
https://t.co/8gJakj9Kmv

[Erling Andreas Tronvik @ErlingTronvik]

Editorial on Enhanced learning in migraine @PetterOmland @NorHeadResearch #migraine #headache @JCephalalgia

https://t.co/PUjdiWMpVV

[Norwegian Centre for Headache Research @NorHeadResearch]

#Arendalsuka2024 nærmer seg! NorHead deltar for tredje gang. Her treffer du oss!: https://t.co/t9crhsxshP

[Cephalalgia @JCephalalgia]

Machine learning can be used to predict which headache research papers will be highly cited and which will be included in guidelines and policy documents.
https://t.co/Og0JJRk4T9
#headache #neurology
@ErlingTronvik
@NorHeadResearch
@Manjit_Matharu